Private credit boom in insurers triggers systemic risk alarms

By 2025, US life insurers, especially those owned by private equity giants KKR and Apollo, have dramatically increased their private credit holdings to $807 billion, constituting roughly 20% of their fixed income portfolios. This surge includes a 30% rise in allocations by KKR’s Global Atlantic Financial Group and Apollo’s Athene Holding, with the asset mix becoming notably complex: 38% of these investments are tied to structured and asset-backed credit, while nearly 10% fall below investment grade, signaling a deliberate shift toward higher-yielding yet riskier instruments.

The expansion of private credit exposure is not only rapid but also highly concentrated, with about 10 large insurers holding $352 billion of these illiquid assets, creating significant risk clustering within a small subset of balance sheets. This concentration amplifies concerns about valuation opacity and liquidity challenges as insurers increasingly converge with private credit markets in their quest for higher yields to match their long-duration liabilities.

Insurers’ natural advantage—patient capital matched to long-dated liabilities—makes them ideal candidates for absorbing illiquid private credit assets, capturing the associated liquidity premium. However, as credit risk migrates from banks to private credit vehicles and then into insurers, it raises systemic concerns; policyholders, akin to bank depositors, expect protection from losses, yet this risk transfer blurs traditional boundaries and invites heightened regulatory scrutiny.

By mid-2026, synthetic risk transfers (SRTs) have emerged as a sophisticated financial engineering tool leveraged by insurers, banks, and fintech firms to manage private credit risk and optimize capital efficiency. Seer Capital’s arrangement of a $300 million insurance-backed financing facility specifically for SRT investments exemplifies the growing institutional infrastructure supporting these transactions. Meanwhile, Klarna’s strategic deployment of multiple large-scale SRTs—including a recent $516 million transfer and a prior €1.7 billion deal—highlights how such mechanisms enable firms to offload significant credit risk and free up capital for growth, underscoring the complexity and scale of these structured finance solutions.

European banks have increasingly adopted SRTs as a precise 'scalpel' to manage diverse private credit exposures, driven primarily by the need for capital relief amid high risk weights on these loans. According to Monsur Hussain of Fitch Ratings, these transactions allow targeting at granular levels—from individual obligors to sectors—covering a broad spectrum of assets including infrastructure loans for renewable energy, subscription lines, NAV lending, and fund finance. Notably, BNP Paribas’s pioneering synthetic securitisation referencing $1.25 billion in revolving credit facilities to US Business Development Companies, placed with Golub, illustrates banks’ innovative use of SRTs to offload risk while navigating a highly private and relationship-driven market.

Despite their benefits, SRTs introduce complexity as heightened regulatory scrutiny and concerns over back leverage have led banks to restrict repo funding availability to SRT investors, complicating financing structures. Beyond regulatory capital relief, banks also deploy SRTs to adhere to internal risk limits and concentration thresholds, effectively optimizing balance sheets and preserving lending capacity in private credit markets. As Alan McNamara notes, this dual purpose reflects banks’ strategic balancing act to free up capacity on financing lines while managing portfolio risk prudently.

The scope of SRT reference pools is expanding beyond traditional credit exposures to include financing provided to private credit firms themselves, signaling a strategic broadening of risk transfer applications. MUFG’s recent transaction exemplifies this trend, demonstrating how banks are innovating to manage and offload risks embedded in private credit financing, thereby reinforcing the evolving role of synthetic risk transfers as versatile tools in the structured finance landscape.

By mid-2026, the insurance sector, particularly life insurers owned by alternative asset managers like KKR and Apollo, has dramatically increased its exposure to private credit, with US life insurers holding approximately $807 billion in illiquid investments by 2025, up from $685 billion the previous year. This concentration is stark: just 10 large insurers account for $352 billion of these assets, amplifying systemic risk through a tightly clustered exposure that echoes the pre-2008 financial crisis dynamics where risk concentration within a few institutions magnified vulnerabilities.

The systemic fragility is compounded by the opaque and illiquid nature of these private credit assets, which lack daily market valuations and instead rely on internal 'mark-to-model' pricing. Unlike publicly traded bonds scrutinized by independent analysts, these bilaterally negotiated loans are valued through proprietary algorithms, potentially masking true losses during downturns. This valuation opacity, coupled with the illiquidity of the assets, threatens pension insurers’ ability to meet obligations in a crisis, as hidden losses may surface too late to allow for timely asset liquidation, risking pension payouts if corporate defaults surge.

Financial engineering strategies currently in vogue—such as UBS’s packaging of private credit fund stakes into bonds with insurance 'wrappers' to achieve investment-grade ratings—mirror the repackaging of toxic assets that precipitated the 2008 crisis. These structures leverage insurer guarantees to drastically reduce regulatory capital requirements, with A2-rated tranches requiring less than 1% capital compared to up to 30% for direct private credit investments. This reliance on insurer credit ratings as a 'magic wand' creates a fragile ecosystem vulnerable to liquidity shocks if downgrades occur, reminiscent of AIG’s collapse when counterparties demanded massive collateral calls.

The transformation of illiquid, below-investment-grade private credit exposures into tradable securities with investment-grade ratings through diversification, tranching, and credit enhancement is raising alarms about a rerun of pre-2008 structured finance excesses. Wall Street’s application of these techniques to one of finance’s fastest-growing asset classes risks masking underlying risks and fostering systemic instability. Market historians warn that despite structural differences, the core risk dynamics—high leverage, lack of transparency, and assumptions of continuous market stability—remain dangerously similar to those that led to the last financial crisis.

By mid-2026, the European Systemic Risk Board (ESRB) had intensified its scrutiny of the burgeoning private credit market, flagging concerns over its rapid expansion and opaque data that could amplify systemic shocks. While the ESRB’s recommendations for stronger oversight and enhanced supervision remain influential yet non-binding, they have catalyzed a wave of regulatory attention focused on the intricate linkages between private credit, banks, and the broader financial system.

European banks, facing increasingly pointed regulatory scrutiny over their private credit exposures, have turned to synthetic risk transfer (SRT) transactions as a surgical tool to manage risk concentrations at granular levels—whether by obligor, sector, or geography. Monsur Hussain of Fitch Ratings highlights that while capital relief is the primary incentive behind these SRTs, banks also deploy them to adhere to internal risk limits and concentration thresholds, reflecting a dual influence of regulatory capital frameworks and supervisory risk management.

Heightened regulatory concerns extend beyond direct exposures to the financing mechanisms underpinning risk transfers, with some banks curtailing repo funding availability amid worries about back leverage and investor financing. This regulatory pressure signals a broader supervisory effort to tighten controls not only on asset risks but also on the structural supports that facilitate risk dispersion in private credit markets.

Addressing the valuation opacity inherent in private credit, regulators are exploring innovative reforms such as imposing capital surcharges on hard-to-value assets—a so-called 'Puvian tax' on opacity—to better align downside risks with insurers. Additionally, proposals to overhaul guarantee fund structures by ending tax credits and adopting a pre-funding model akin to federal deposit insurance aim to bolster transparency and risk management. These valuation-based reforms respond to widespread agreement that private letter ratings are overly optimistic and that bespoke, non-tradable private credit assets pose structural valuation challenges.

By mid-2026, the private equity industry had clearly bifurcated into two distinct camps: large, mostly publicly traded asset managers with expansive lending and insurance operations, and smaller specialist firms continuing traditional leveraged buyouts reminiscent of Henry Kravis's style. This division blurs the conventional understanding of 'private equity,' complicating regulatory oversight and raising alarms about potential systemic risks that could prompt reforms akin to the post-2008 Dodd-Frank Act interventions.

Following the 2008 financial crisis, policymakers deliberately shifted credit risk away from banks to private credit vehicles to prevent taxpayer-funded bailouts, but this risk has since migrated into the insurance sector. Insurers, while possessing long-dated liabilities and patient capital that make them natural holders of illiquid private credit assets, now face new vulnerabilities as their policyholders—much like bank depositors—are socially trusted not to bear losses, creating a precarious systemic exposure.

This structural evolution—credit risk moving from regulated banks to private credit entities and then into insurers—reveals a profound shift in financial market dynamics. Despite differences in redemption schedules, insurers and banks share fundamental business risks, and the migration of private credit risk into insurance complicates financial stability and investor protection, underscoring the need for nuanced regulatory frameworks that address these converging vulnerabilities.